⌘K

Home/Filings/4/0001123292-21-000492

4//SEC Filing

Cobourn Steven P. 4

Accession 0001123292-21-000492

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 4:44 PM ET

Size

5.2 KB

Accession

0001123292-21-000492

Insider Transaction Report

Form 4

Period: 2021-03-15

NextCure, Inc.NXTC

Cobourn Steven P.

Chief Financial Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2021-03-15+100,000→ 100,000 total
Exercise: $12.59Exp: 2031-03-14→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]One fourth of the option vests on March 15, 2022. The remainder vests in 36 monthly installments beginning on April 15, 2022.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1

filerCIK 0001775457

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 4:44 PM ET
Size: 5.2 KB

View on SEC.gov